Xylo Technologies
XYLO
XYLO was delisted on the 21st of August, 2025.
5 hedge funds and large institutions have $10K invested in Xylo Technologies in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.06% less ownership
Funds ownership: 0.26% → 0.19% (-0.06%)
30% less capital invested
Capital invested by funds: $14.3K → $10K (-$4.3K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.8K |
| 2 |
GWSA
Global Wealth Strategies & Associates
Denver,
Colorado
|
+$16 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$3.76K |
| 2 |
JP Morgan Chase
New York
|
-$91 |
XYLO Hedge Fund Activity: Q1 2024 in Review
5 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Xylo Technologies (XYLO) for Q1 2024, worth a combined $10K — down 30% from $14.3K a quarter earlier.
Fund positioning in XYLO was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.8K. The largest seller was UBS Group, cutting an estimated $3.76K.
- 5 institutional investors held Xylo Technologies (XYLO) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $10K of Xylo Technologies stock for Q1 2024, down 30% quarter-over-quarter.
- 1 fund opened new Xylo Technologies positions in Q1 2024 and 1 closed out, a net change of 0 holders.
- The largest Xylo Technologies buyer in Q1 2024 was Morgan Stanley, an estimated $1.8K added.
- The largest Xylo Technologies seller in Q1 2024 was UBS Group, an estimated $3.76K sold.
Based on aggregated 13F filings for Q1 2024.